ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEEHUPLSKBAHRIS..MTNORSMESM..................*JBDM Ver 0.1.63 (23 May 2017) - 2999001/03099684CORRECTED EUROPEAN PATENT SPECIFICATIONB8B120180704W173deBibliographieenBibliographyfrBibliographieEP15705417.2201501282016082520170516enenen201461933246 P20140129US201462078895 P20141112US2018070420182720161207201649201804042018142017101920180704201827C07D 417/14 20060101AFI20170928BHEP C07D 403/12 20060101ALI20170928BHEP C07D 417/12 20060101ALI20170928BHEP A61K 31/4045 20060101ALI20170928BHEP C07D 413/12 20060101ALI20170928BHEP deHETEROARYLAMIDE ALS INHIBITOREN DER PROTEINAGGREGATIONenHETEROARYL AMIDES AS INHIBITORS OF PROTEIN AGGREGATIONfrAMIDES HÉTÉROARYLES COMME INHIBITEURS DE L'AGRÉGATION PROTÉIQUEWO-A1-2010/142801WO-A1-2011/08464218156929.420180215STOCKING, Emily, M.c/o Neuropore Therapies, Inc. 10835 Road to the Cure, Suite 210San Diego, CA 92121USWRASIDLO, Wolfgangc/o Neuropore Therapies, Inc. 10835 Road to the Cure, Suite 210San Diego, CA 92121USUCB Biopharma SPRL101523400WJW/FP7218514Allée de la Recherche 601070 BrusselsBEWytenburg, Wilhelmus Johanneset al100058995Mewburn Ellis LLPCity Tower 40 Basinghall Street London EC2V 5DEGBALATBEBGCHCYCZDEDKEEESFIFRGBGRHRHUIEISITLILTLULVMCMKMTNLNOPLPTRORSSESISKSMTRBA20160825ME20160825US201501326320150128enWO201511666320150806201531